开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2023-09-25 ms9000000940325280 来自湖北省

审稿速度:1.0
经验分享：还行

113 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2024-08-08 ms2000000216251923 来自青海省

偏重的研究方向：神经科学;行为学研究
经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2023-12-12 14703350m46(暂无昵称) 来自天津

偏重的研究方向：行为学;神经保护
经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊

91 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2024-07-05 ms2000000216251923 来自青海省

偏重的研究方向：神经病学;行为学研究
经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？

66 0

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2021-09-27 Jason2021

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经科学;神经保护;行为学研究
经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online

152 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2024-02-26 ms5000001014751680 来自北京

观后感

84 0

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2023-05-15 121ccd8dm34(暂无昵称)

各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？

125 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2022-10-14 ms1000000582200464

偏重的研究方向：肿瘤
经验分享：脑癌可以投稿这个杂质吗

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2023-08-17 ms3000001512295561 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：神经行为学;糖尿病
经验分享：2023.08.06 投稿
2023.08.07 Received by Editor
2023.08.17 Received by Editor
好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏

117 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2219191, encodeId=ac0a221919119, content=偏重的研究方向：神经科学;行为学研究 经验分享：一审返修后 receive by editor 20天了，是什么情况啊，可以写邮件催一下编辑不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Thu Aug 08 22:13:31 CST 2024, time=2024-08-08, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向：行为学;神经保护 经验分享：一审大修，二审小修，修回去10天了，一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2213506, encodeId=2d03221350611, content=偏重的研究方向：神经病学;行为学研究 经验分享：请问大家，研究性的文章，后期要求上传伦理审查批件吗，要求伦理编号不？我的伦理审查批件上没有伦理编号还可以用吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Fri Jul 05 23:20:31 CST 2024, time=2024-07-05, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;神经保护;行为学研究 经验分享：审稿速度还可以，一审三个审稿人，每个人都提出比较犀利的问题，一审修回去的时候，认真回复每一个审稿人的问题，总体上还算快，赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友，投稿半个月状态：Editor Decision Made ；是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向：肿瘤 经验分享：脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经行为学;糖尿病 经验分享：2023.08.06 投稿 2023.08.07 Received by Editor 2023.08.17 Received by Editor 好焦灼啊，在编辑那里已经10天了，一直在编辑手里，还能送审吗，各位朋友们也是这样吗，希望大神指点迷津，谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向：fMRI 经验分享：请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西)]

2023-05-27 ms5000001864785048 来自广西

偏重的研究方向：fMRI
经验分享：请问大家in reviewer agreement多久可以发邮件问问啊

0 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务